ConductScience.org, home
A Clinical Study in Subjects With Neuropathic Pain From PHN Who Have Had an Inadequate Response to Gabapentin Treatment
API referenceFor AI assistants

Trial · NCT00617461

Participant flow24

How many started, completed or left each group, period by period.

1 to 20 of 24

Download this page as JSON
PeriodMilestoneGroupParticipantsUnits counted
First Treatment Intervention PeriodSTARTEDGEn 1200 mg/Day Followed by GEn 3600 mg/Day52
First Treatment Intervention PeriodSTARTEDGEn 3600 mg/Day Followed by GEn 1200 mg/Day44
First Treatment Intervention PeriodCOMPLETEDGEn 1200 mg/Day Followed by GEn 3600 mg/Day42
First Treatment Intervention PeriodCOMPLETEDGEn 3600 mg/Day Followed by GEn 1200 mg/Day41
First Treatment Intervention PeriodNOT COMPLETEDGEn 1200 mg/Day Followed by GEn 3600 mg/Day10
First Treatment Intervention PeriodNOT COMPLETEDGEn 3600 mg/Day Followed by GEn 1200 mg/Day3
4-Day Crossover PeriodSTARTEDGEn 1200 mg/Day Followed by GEn 3600 mg/Day42
4-Day Crossover PeriodSTARTEDGEn 3600 mg/Day Followed by GEn 1200 mg/Day40
4-Day Crossover PeriodCOMPLETEDGEn 1200 mg/Day Followed by GEn 3600 mg/Day41
4-Day Crossover PeriodCOMPLETEDGEn 3600 mg/Day Followed by GEn 1200 mg/Day40
4-Day Crossover PeriodNOT COMPLETEDGEn 1200 mg/Day Followed by GEn 3600 mg/Day1
4-Day Crossover PeriodNOT COMPLETEDGEn 3600 mg/Day Followed by GEn 1200 mg/Day0
Second Treatment Intervention PeriodSTARTEDGEn 1200 mg/Day Followed by GEn 3600 mg/Day41
Second Treatment Intervention PeriodSTARTEDGEn 3600 mg/Day Followed by GEn 1200 mg/Day41
Second Treatment Intervention PeriodCOMPLETEDGEn 1200 mg/Day Followed by GEn 3600 mg/Day41
Second Treatment Intervention PeriodCOMPLETEDGEn 3600 mg/Day Followed by GEn 1200 mg/Day37
Second Treatment Intervention PeriodNOT COMPLETEDGEn 1200 mg/Day Followed by GEn 3600 mg/Day0
Second Treatment Intervention PeriodNOT COMPLETEDGEn 3600 mg/Day Followed by GEn 1200 mg/Day4
6-Day Down-Titration PeriodSTARTEDGEn 1200 mg/Day Followed by GEn 3600 mg/Day41
6-Day Down-Titration PeriodSTARTEDGEn 3600 mg/Day Followed by GEn 1200 mg/Day37

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Next page

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00617461/flow

API referenceFor AI assistants